Adaptin Bio (APTN) Non-Current Debt (2022 - 2024)

Adaptin Bio has disclosed Non-Current Debt across 3 years of filings, most recently posting $31000.0 for Q3 2024.

• In Q3 2024, Non-Current Debt rose 63.16% year-over-year to $31000.0; the TTM figure through Sep 2024 stood at $31000.0 (up 63.16% YoY), while the FY2023 annual figure was $81219.0, up 1524.38% from the prior year.
• Non-Current Debt came in at $31000.0 for Q3 2024 at Adaptin Bio, up from $28000.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $81219.0 in Q4 2023 to a low of $5000.0 in Q4 2022.
• Average Non-Current Debt over 3 years is $40906.3, with a median of $29500.0 recorded in 2024.
• Year-over-year, Non-Current Debt surged 1524.38% in 2023 and jumped 63.16% in 2024.
• Over 3 years, Non-Current Debt stood at $5000.0 in 2022, then surged by 1524.38% to $81219.0 in 2023, then tumbled by 61.83% to $31000.0 in 2024.
• Per Business Quant data, the three most recent Non-Current Debt figures were $31000.0 in Q3 2024, $28000.0 in Q2 2024, and $81219.0 in Q1 2024.